PT1424334E - Derivado de quinazolinona - Google Patents

Derivado de quinazolinona Download PDF

Info

Publication number
PT1424334E
PT1424334E PT02755797T PT02755797T PT1424334E PT 1424334 E PT1424334 E PT 1424334E PT 02755797 T PT02755797 T PT 02755797T PT 02755797 T PT02755797 T PT 02755797T PT 1424334 E PT1424334 E PT 1424334E
Authority
PT
Portugal
Prior art keywords
alkyl group
quinazolinone derivative
onü
äwherein
pollakiuria
Prior art date
Application number
PT02755797T
Other languages
English (en)
Inventor
Naohito Ohashi
Kazuki Matsui
Koji Morishita
Masami Muraoka
Takaaki Yamamoto
Masatoshi Yuri
Seiji Katayama
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Publication of PT1424334E publication Critical patent/PT1424334E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT02755797T 2001-08-09 2002-08-02 Derivado de quinazolinona PT1424334E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001241955 2001-08-09

Publications (1)

Publication Number Publication Date
PT1424334E true PT1424334E (pt) 2008-01-10

Family

ID=19072309

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02755797T PT1424334E (pt) 2001-08-09 2002-08-02 Derivado de quinazolinona

Country Status (13)

Country Link
US (1) US7329665B2 (pt)
EP (1) EP1424334B1 (pt)
JP (1) JP4087337B2 (pt)
KR (1) KR100824506B1 (pt)
CN (1) CN1307172C (pt)
AT (1) ATE376546T1 (pt)
CA (1) CA2457351C (pt)
DE (1) DE60223151T2 (pt)
DK (1) DK1424334T3 (pt)
ES (1) ES2295382T3 (pt)
PT (1) PT1424334E (pt)
TW (1) TWI308567B (pt)
WO (1) WO2003016299A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8673353B2 (en) 2008-02-11 2014-03-18 Dainippon Sumitomo Pharma Co., Ltd Tablet having improved elution properties
EP2363397A4 (en) 2008-11-07 2012-07-11 Dainippon Sumitomo Pharma Co NEW THERAPEUTIC AGENT USEFUL FOR SYMPTOM OF LOWER URINARY TRACT
WO2016199161A2 (en) * 2015-06-12 2016-12-15 Swati Vishal Jajodia A composition comprising pentosan polysulfate sodium for use in treatment of bladder outlet obstruction and/or lower urinary tract symptoms

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE174908T1 (de) * 1993-05-26 1999-01-15 Sumitomo Pharma Chinazolinonderivate
JP4484368B2 (ja) * 1998-10-16 2010-06-16 大日本住友製薬株式会社 キナゾリノン誘導体

Also Published As

Publication number Publication date
KR20040020081A (ko) 2004-03-06
DK1424334T3 (da) 2008-02-11
US7329665B2 (en) 2008-02-12
CA2457351A1 (en) 2003-02-27
DE60223151T2 (de) 2008-08-07
CN1538966A (zh) 2004-10-20
EP1424334A4 (en) 2005-05-04
ATE376546T1 (de) 2007-11-15
CN1307172C (zh) 2007-03-28
US20050032819A1 (en) 2005-02-10
KR100824506B1 (ko) 2008-04-22
WO2003016299A1 (fr) 2003-02-27
TWI308567B (pt) 2009-04-11
JPWO2003016299A1 (ja) 2004-12-02
JP4087337B2 (ja) 2008-05-21
EP1424334B1 (en) 2007-10-24
DE60223151D1 (de) 2007-12-06
EP1424334A1 (en) 2004-06-02
ES2295382T3 (es) 2008-04-16
CA2457351C (en) 2010-01-12

Similar Documents

Publication Publication Date Title
DE60236851D1 (en) Pyrimidinmatrixmetalloproteinaseinhibitoren
WO2003029199A1 (fr) Derives de benzene et procede de preparation et d'utilisation associe
WO2003039461A3 (en) Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
GB0318343D0 (en) No title
ATE339409T1 (de) Trizyklische verbindungen
WO2002044153A8 (en) 4-6-diphenyl pyridine derivatives as antiinflammatory agents
WO2004063330A3 (en) (2-carboxamido) (3-amino) thiophene compounds
EP1357124A4 (en) HETEROCYCLIC COMPOUNDS AND COMPOSITIONS IMPROVING CEREBRAL FUNCTIONS CONTAINING THESE AS ACTIVE INGREDIENTS
EP1424334A4 (en) QUINAZOLINONE DERIVATIVE
CA2366205A1 (en) Biphenyl derivatives
EP1122253A4 (en) QUINALOZINON DERIVATIVES
NZ501785A (en) 4-(3,4-dihydro-2-naphthylmethyl)- or 4-(2H-3-chromenylmethyl)-4,5-dihydro-1H-imidazole derivatives
RS99504A (en) 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
WO2004099130A3 (en) 1,2-diarylimidazoles useful as inhibitors of cox
WO2002080918A1 (fr) Agent therapeutique ou prophylactique en cas de miction frequente ou d'incontinence urinaire
WO2002060878A1 (en) Benzimidazolidinone derivatives
MY133601A (en) Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23
DK1049672T3 (da) Azetidincarboxamid-derivater til behandling af CNS-lidelser
WO2003027060A1 (fr) Derives amide de diphenylbutane
WO2003087059A3 (en) (e)-oxime ether derivative of 5,6-dihydro-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one
PL364794A1 (en) 2-aminotetralin derivatives for the therapy of glaucoma
DK1049670T3 (da) Azetidincarboxamidderivater til behandling af CNS-lidelser
EP1650199A4 (en) SULPHONAMIDE DERIVATIVE WITH ISOXAZOL RING
AU2002214266A1 (en) Carbamate derivatives, process for producing the same and use thereof
DK1282625T3 (da) Anvendelsen af benzoxaziner i behandlingen af Parkinsons sygdom